
Charcoal-Free Shisha Significantly Less Harmful Than Traditional Shisha and Cigarettes, New Study Reveal
The world's first charcoal-free shisha product, OOKA, emits substantially lower levels of harmful and potentially harmful constituents (HPHCs) than both traditional charcoal-heated waterpipes and combustible cigarettes, according to a new peer reviewed study published today in Nature's Scientific Reports. The study provides substantive new evidence that OOKA, developed by AIR, the global social inhalation company behind leading shisha brand Al Fakher, is a breakthrough in harm reduction, delivering one of the cleanest inhalation experiences currently available without any compromise on flavour and experience for users.
Conducted by ISO 17025 accredited ASL Analytic Service Laboratory GmbH in Germany, the study tested emissions from OOKA across 37 toxicants, including carbon monoxide, aldehydes and tobacco-specific nitrosamines (TSNAs) – chemicals associated with serious health risks such as cancer, cardiovascular and respiratory disease.
When tested, emissions from OOKA showed zero detection of many of the most harmful by-products of combustion – including carbon monoxide, benzene, toluene and benzo[a]pyrene – substances typically found in both cigarettes and charcoal-heated shisha.
The study also showed that emissions of key aldehydes – including acrolein, acetaldehyde and formaldehyde – were reduced by up to 96% in the charcoal-free device compared to traditional shisha. When typical real-world consumption is factored in, toxicant exposure was estimated to be up to 100 times lower than cigarette smoking.
Compared to other formats such as heat management devices (HMDs) used with traditional waterpipes and heated tobacco products (HTPs), the charcoal free shisha device consistently outperformed across most toxicant measures.
Furthermore, in contrast to the habitual daily use of cigarettes, toxicant exposure from even traditional shisha use is proven to be significantly lower due to both the chemical profile of the aerosol and to its infrequent consumption – typically once or twice per week. As a result, most users' total intake from waterpipe smoking is substantially reduced.
Dr Ian Fearon, co-author and a leading global expert in the scientific basis for tobacco harm reduction commented: 'These findings have significant implications, not just for public health but also for shisha regulation and consumer understanding. Misconceptions around waterpipe use have gone unchallenged for too long, and studies like this help bring clarity and credible data to a rapidly evolving category.'
Ronan Barry, Chief Regulatory & Legal Officer at AIR, further commented: 'The OOKA was designed to deliver a modern shisha experience that doesn't compromise on enjoyment, while significantly reducing exposure to toxicants. By removing charcoal and precisely controlling heating temperatures, we've virtually eliminated most of the high-risk compounds typically associated with waterpipe use.
'I hope that the findings in this study will stimulate new conversations and open new avenues for charcoal-free shisha devices to be rolled out further around the world, in line with the anticipated increase in consumer demand. We are ready and willing to partner with decision makers and authorities, and engage in open and transparent dialogue, to make this a reality.'
As the first electronically heated shisha system, OOKA represents a major advancement in inhalation technology – providing a charcoal-free, smoke-free experience without compromising flavor or ritual. The product's multi-patented design eliminates combustion-related toxicants while offering consumers a consistent and premium experience.
The research supports existing studies that suggest waterpipe use may result in lower exposure to harmful chemicals than cigarette smoking. The findings also affirm OOKA's potential to be a category-defining product that aligns with broader harm reduction strategies across the tobacco and nicotine industries. As regulators and health authorities worldwide continue to evaluate alternatives to combustible products, AIR remains committed to science-backed innovation and transparent engagement to support evidence-based decision making

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Khaleej Times
a day ago
- Khaleej Times
The art of seasonal scents: Choosing the right perfume for every season
Perfume is a deeply personal luxury, an invisible signature that lingers long after you leave the room. It has the power to uplift your mood, spark memories, and transform even the most ordinary days into sensory moments. From the delicate burst of florals in spring to the warm embrace of oud in winter, the right fragrance can capture the essence of a season with just one spritz. As seasons shift, so too does the way perfume interacts with your skin and environment. Summer's warmth can intensify lighter scents, making citrus and aquatic notes feel fresh and vibrant, while cooler months are perfect for rich, full-bodied compositions like amber, musk, and spice. Wearing perfume in harmony with the weather not only enhances its impact but also adds a touch of sophistication to your daily ritual. With the help an expert insight, you can explore the delicate balance between choosing fragrances that match the mood of each season, while also being kind to your skin and body. Whether you're layering your signature scent or discovering new seasonal favorites, let this guide inspire a more mindful and elegant way to wear fragrance; one that complements your style, the seasons, and your sense of wellbeing. Spring: A time for florals and fresh starts Spring welcomes lighter, breezier notes that mirror the rebirth of nature. Think peonies, lilies, green tea, or citrusy neroli. After the musky cocoon of winter, your body and nose crave something fresher. However, if you're prone to allergies, this season might come with a caveat. Dr Suresh Puri, Consultant Pulmonologist and Internal Medicine at JTS Medical Centre, Dubai, advises caution with fragrance choices, particularly for those with health sensitivities. 'Use scent-free products, try avoiding strong perfumes including smoky (Bakhur) fragrance,' he suggests. As some stronger scents may trigger respiratory reactions and create a stuffy indoor environment, especially if ventilation is poor. For spring, alcohol-free body mists or eau de toilette versions of your favorite fragrances; are suggested as they're usually less concentrated and less likely to overwhelm. Summer: Light, airy, and skin-safe The heat of summer calls for crisp, clean fragrances that won't become cloying in the sun. Popular choices include marine notes, citrus, and fruity blends like watermelon or grapefruit. But with increased sweating and sun exposure, fragrance application becomes tricky, especially for people with sensitive skin. Dr Teena Mathew, Specialist Dermatologist at JTS Medical Centre, Dubai, highlights the importance of skin health when using perfumes. 'For people with sensitive skin wishing to use fragrances, it is best to conduct a usage test. Apply it to a small inconspicuous area for two weeks. If there is no reaction, then it should be safe to use,' she explains. She also emphasises the need for proper skin hydration: 'It is important to keep the skin well moisturised since dry skin can precipitate irritation.' In other words, layering a good unscented moisturiser underneath your fragrance not only helps the scent last longer but also forms a barrier that protects the skin. So, for summers, it's best to opt for oil-based perfumes — they tend to be gentler on the skin and evaporate less quickly. Autumn: Warm, spicy, and grounding As temperatures drop and the air gets crisp, we begin to crave more warmth and that extends to our fragrance choices. Autumn is the season of vanilla, amber, sandalwood, and fig. These rich, spicy, and slightly sweet aromas mimic the cozy feeling of sweater weather. This is also a good time to explore niche or artisanal scents that evoke earthy tones and natural elements. But it's important to be mindful of where and how you apply these stronger perfumes. For individuals with sensitive skin or eczema, direct application on pulse points like the neck or behind the ears can trigger irritation. Dr Mathew suggests, 'Spraying fragrance on clothes instead of directly on the skin can help minimise contact with potential irritants.' Just be sure to test it on a small patch of fabric first to avoid staining. In cooler months, your skin tends to be drier. 'It is also important is to keep the skin well moisturised since dry skin can precipitate skin irritation,' she added. Winter: Bold, deep, and intimate Winter invites bold fragrances with depth; think oud, patchouli, leather, musk, and incense. These perfumes shine in colder temperatures and linger longer in the dry winter air. However, heavier scents can sometimes feel overwhelming, especially indoors or in confined spaces. Dr Puri warns against using smoky or overpowering scents. 'Have a well-ventilated home and workplace environment,' he advises, adding that scent-heavy spaces can negatively affect respiratory health. This is especially relevant during the holiday season when candles, incense, and perfumes are used simultaneously. A good rule of thumb is to balance your olfactory space, if you're lighting a strongly-scented candle, maybe skip the heavy perfume that day. Layering is key in winter. Start with a scented body wash, follow up with a matching lotion, and finish with a spritz of perfume to lock in the fragrance all day. Year-round wellness: Finding balance with fragrance No matter the season, your fragrance should enhance your day. With the rise of clean beauty and dermatologically tested perfumes, consumers now have access to options that are safer for both the skin and the lungs. If you have asthma, allergies, or sensitive skin, patch testing is essential. As Dr Mathew stresses, 'A two-week trial on a small skin area can help detect any delayed allergic reactions.' It may seem tedious, but it's worth it if it saves you from irritation or discomfort. Equally important is ventilation. 'Avoid strong perfumes and ensure your environment is well-ventilated,' says Dr Puri. This small habit can significantly improve indoor air quality and overall wellbeing, especially if you use fragrance daily. You might also consider scented hair mists, lightly fragranced deodorants, or diffuser oils in your personal space to maintain a subtle and pleasant scent. Scent with sensibility Lastly, wearing perfume isn't just about smelling good; it's about feeling good too. It's about understanding your body, your skin's needs, and the subtle ways your surroundings shape how a scent is received. A well-chosen fragrance can be a quiet act of self-care, a daily ritual that speaks to your mood, your story, and your sense of place. By tuning into the rhythm of the seasons and being mindful of your skin's sensitivity and others' comfort, you transform perfume from a fleeting indulgence into something more meaningful. You give it thought, intention, and grace. So, whether you're layering notes of jasmine on a spring morning or wrapping yourself in the velvet of oud on a winter's night, let your scent echo something deeper, your awareness, your wellbeing, and your respect for those around you. Because in a world full of noise, sometimes the softest things like a well-chosen fragrance can leave the strongest impression.


Zawya
19-05-2025
- Zawya
LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media
HANOI, VIETNAM - Media OutReach Newswire - 19 May 2025 - LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children. This marks the third consecutive study on the product published in a prestigious international scientific platform, reinforcing a promising new direction in non-antibiotic respiratory care. The findings from the clinical study, conducted Thai Binh University of Medicine and Pharmacy in collaboration with other institutions, was published on January 27, 2025, in Scientific Reports-Nature, a renowned journal under the Nature Portfolio (UK). The results demonstrated significant effectiveness in children within just 3–7 days of use. Additionally, data also showed positive improvements in adults, highlighting the product's potential for broader application in the future. The study was carried out from November 2023 to December 2024 with the participation of 126 patients, including both children and adults. Among children with acute rhinosinusitis and perforated acute otitis media, the treatment results were particularly notable: after 3 days of using LiveSpo® NAVAX, nasal congestion decreased by 68%, twice as much as the saline group. After 7 days, 97% of the children had no more nasal discharge, and 100% had no more ear discharge. The concentration of pathogenic bacteria Streptococcus pneumoniae in nasal and ear secretions dropped more than 1,200 times. Importantly, no side effects were recorded during the entire trial – even in children with weakened immune systems. In the adult group with acute sinusitis, symptoms such as nasal congestion, facial pain, and purulent discharge improved significantly after 3 days of use – with reductions of 53%, 78%, and 61%, respectively. After 7 days, 91% of patients no longer experienced nasal discharge. Laboratory results showed a substantial reduction in pathogenic bacteria: Streptococcus pneumoniae decreased over 380-fold and Haemophilus influenzae decreased over 49,000-fold compared to the Control group receiving physiological saline According to the research team, the effectiveness of LiveSpo® NAVAX origins from its ability to modulate local inflammatory responses and enhance mucosal immunity through the competitive biological mechanism of spore-forming Bacillus probiotics. Inflammatory markers such as IL-6, IL-8, and TNF-α significantly decreased, while levels of IgA – a key protective antibody at the mucosal surface – increased, contributing to the restoration of the nose and ear's natural defense barrier. This study not only adds to the growing body of scientific evidence supporting LiveSpo® NAVAX's efficacy in respiratory care but also affirms Vietnam's biomedical research capabilities on the international scientific map. It paves the way for a safe, sustainable respiratory treatment alternative that reduces reliance on antibiotics – especially for vulnerable groups like children. Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo Pharma, shared: "At LiveSpo, we prioritize the research and development of internationally standardized products, combining modern medicine with advanced probiotic technology to deliver safe and effective health solutions for the community – all with a vision of A Future Without Antibiotics." References: Khieu TH, Le DP, Nguyen BT, Ngo BT, Chu HT, Truong DM, Nguyen HM, Nguyen AH, Pham TD, Van Nguyen AT. Alleviating symptoms of paediatric acute rhinosinusitis and acute otitis media with otorrhea using nasal-spraying Bacillus probiotics: a randomized controlled trial. Sci Rep. 2025 Jan 27;15(1):3410. doi: 10.1038/s41598-025-87372-2. PMID: 39870748; PMCID: PMC11772584. Hashtag: #LiveSpo The issuer is solely responsible for the content of this announcement. About LiveSpo Pharma LiveSpo is an R&D, manufacturing, and distribution brand of Clinically Proven Medical Probiotics, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for "A Future Without Antibiotics". Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores - Spobiotic - will pave the way to a future without antibiotics for everyone. Hotline: 1800.088808 Website: LiveSpo


Arabian Post
19-05-2025
- Arabian Post
LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media
The findings from the clinical study, conducted Thai Binh University of Medicine and Pharmacy in collaboration with other institutions, was published on January 27, 2025, in Scientific Reports-Nature, a renowned journal under the Nature Portfolio (UK). The results demonstrated significant effectiveness in children within just 3–7 days of use. Additionally, data also showed positive improvements in adults, highlighting the product's potential for broader application in the future. The study was carried out from November 2023 to December 2024 with the participation of 126 patients, including both children and adults. Among children with acute rhinosinusitis and perforated acute otitis media, the treatment results were particularly notable: after 3 days of using LiveSpo® NAVAX, nasal congestion decreased by 68%, twice as much as the saline group. After 7 days, 97% of the children had no more nasal discharge, and 100% had no more ear discharge. The concentration of pathogenic bacteria Streptococcus pneumoniae in nasal and ear secretions dropped more than 1,200 times. Importantly, no side effects were recorded during the entire trial – even in children with weakened immune systems. In the adult group with acute sinusitis, symptoms such as nasal congestion, facial pain, and purulent discharge improved significantly after 3 days of use – with reductions of 53%, 78%, and 61%, respectively. After 7 days, 91% of patients no longer experienced nasal discharge. Laboratory results showed a substantial reduction in pathogenic bacteria: Streptococcus pneumoniae decreased over 380-fold and Haemophilus influenzae decreased over 49,000-fold compared to the Control group receiving physiological saline According to the research team, the effectiveness of LiveSpo® NAVAX origins from its ability to modulate local inflammatory responses and enhance mucosal immunity through the competitive biological mechanism of spore-forming Bacillus probiotics. Inflammatory markers such as IL-6, IL-8, and TNF-α significantly decreased, while levels of IgA – a key protective antibody at the mucosal surface – increased, contributing to the restoration of the nose and ear's natural defense barrier. This study not only adds to the growing body of scientific evidence supporting LiveSpo® NAVAX's efficacy in respiratory care but also affirms Vietnam's biomedical research capabilities on the international scientific map. It paves the way for a safe, sustainable respiratory treatment alternative that reduces reliance on antibiotics – especially for vulnerable groups like children. Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo Pharma, shared: 'At LiveSpo, we prioritize the research and development of internationally standardized products, combining modern medicine with advanced probiotic technology to deliver safe and effective health solutions for the community – all with a vision of A Future Without Antibiotics.' References: Khieu TH, Le DP, Nguyen BT, Ngo BT, Chu HT, Truong DM, Nguyen HM, Nguyen AH, Pham TD, Van Nguyen AT. Alleviating symptoms of paediatric acute rhinosinusitis and acute otitis media with otorrhea using nasal-spraying Bacillus probiotics: a randomized controlled trial. Sci Rep. 2025 Jan 27;15(1):3410. doi: 10.1038/s41598-025-87372-2. PMID: 39870748; PMCID: PMC11772584. Hashtag: #LiveSpo The issuer is solely responsible for the content of this announcement. About LiveSpo Pharma LiveSpo is an R&D, manufacturing, and distribution brand of Clinically Proven Medical Probiotics, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for 'A Future Without Antibiotics'. Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores – Spobiotic – will pave the way to a future without antibiotics for everyone. Hotline: 1800.088808 Website: